Ireland is currently involved in an EU Procurement Exercise being operated by the European Commission on behalf of member states to procure a portfolio of suitable, safe and effective vaccines, in sufficient quantities, to combat COVID-19.
As part of the exercise, Ireland has already opted into an Advance Purchase Agreements with AstraZeneca (partnering with Oxford University); Janssen (Johnson & Johnson); BioNTech / Pfizer; CureVac and Moderna.
The content of the Advance Purchase Agreements, including with regard to liability / indemnity, are negotiated with vaccine suppliers by the European Commission and its negotiation team acting on behalf of Member States. Member States may decide to opt in / opt out, but do not have scope to recast the provisions of any APA. Responsibility for claims management will be assigned to the State Claims Agency.